Arquivos do Autor:
Worldwide Regulatory Convergence for Medical Devices – ANVISA as an active regulatory authority towards this goal
Worldwide Regulatory Convergence for Medical Devices – ANVISA as an active regulatory authority towards this goal In recent years, ANVISA’s medical devices department has been working with guidelines based on global regulatory convergence and product risk. On the 2020-2023 Strategic Plan, ANVISA (Brazilian National Health Surveillance Agency) expressed interest in adopting regulatory strategies for simplification, […]
MDSAP
Another achievement for NCC MDSAP medical Device Single Audit Program We are now part of the MDSAP, Health Product Single Audit Program. ANVISA recognized NCC as the organization able to offer this service, which proves our experience in complying with complex and demanding regulations regarding quality, performance, and end-user safety. Contact our commercial team to […]
Recent Comments